TrialPhytotherapy research : PTR2017

Evaluation of Benefit and Tolerability of IQP-CL-101 (Xanthofen) in the Symptomatic Improvement of Irritable Bowel Syndrome: A Double-Blinded, Randomised, Placebo-Controlled Clinical Trial.

Felix Alt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.